TUNICRIS-julkaisut - Trepo

Viitteet 1-1 / 1

Three dose levels of a maternal respiratory syncytial virus vaccine candidate are well tolerated and immunogenic in a randomized trial in non-pregnant women

Schwarz, Tino F; Johnson, Casey; Grigat, Christine; Apter, Dan; Csonka, Peter; Lindblad, Niklas; Nguyen, Thi Lien-Anh; Gao, Feng F; Qian, Hui; Tullio, Antonella N; Dieussaert, Ilse; Picciolato, Marta; Henry, Ouzama (15.06.2021)
article

<p>BACKGROUND: Respiratory syncytial virus (RSV) causes respiratory tract infections, which may require hospitalization especially in early infancy. Transplacental transfer of RSV antibodies could confer protection ...